Related Experiment Videos
Dynamic analysis of STAT6 signalling in living cells
Glyn Nelson1, Geraint J C Wilde, David G Spiller
1School of Biological Sciences, Life Sciences Building, University of Liverpool, Crown St., Liverpool L69 7ZB, UK.
FEBS Letters
|December 3, 2002
Summary
This study shows that Nuclear Factor kappa B (NF-kappaB) activation inhibits STAT6 signaling. NF-kappaB activation repressed STAT6-dependent transcriptional activity and IL-4-induced activation.
Area of Science:
- Molecular Biology
- Cellular Biology
- Immunology
Background:
- Signal transducer and activator of transcription 6 (STAT6) is a key transcription factor mediating interleukin-4 (IL-4) signaling.
- Understanding STAT6 localization and activity is crucial for comprehending immune responses and cellular communication.
- Investigating interactions between different signaling pathways, such as STAT6 and NF-kappaB, can reveal novel regulatory mechanisms.
Purpose of the Study:
- To characterize the functional activity of N- and C-terminal EGFP-STAT6 fusion proteins.
- To investigate the cellular localization of these fusion proteins in response to IL-4 stimulation.
- To explore the potential inhibitory effect of Nuclear Factor kappa B (NF-kappaB) activation on STAT6 signaling.
Main Methods:
- Construction and expression of N-terminal (EGFP-STAT6) and C-terminal (STAT6-EGFP) fusion proteins.
- Assessment of IL-4-dependent transcriptional activation of STAT6.
- Analysis of STAT6 nuclear translocation using fluorescence microscopy in HEK-293 and HeLa cells.
- Evaluation of the impact of TNFalpha stimulation and p65-EGFP expression on STAT6 activity.
Main Results:
- Both EGFP-STAT6 fusion proteins exhibited IL-4-dependent transcriptional activation and nuclear translocation.
- The N-terminal EGFP-STAT6 fusion protein showed higher activity compared to the C-terminal fusion.
- Distinct patterns of nuclear accumulation were observed in HEK-293 (foci formation) and HeLa cells (homogeneous accumulation).
- Activation of the NF-kappaB pathway via TNFalpha or p65-EGFP expression significantly repressed basal STAT6 activity and IL-4-induced activation.
Conclusions:
- The study successfully demonstrated the functional activity and cellular localization of EGFP-STAT6 fusion proteins.
- NF-kappaB activation represents a novel inhibitory mechanism for STAT6 signaling.
- These findings provide new insights into the cross-talk between NF-kappaB and STAT6 pathways, impacting immune cell function.